Steve Kalloger

8PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsSolid tumoursPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 13, 2023
Loss of ATG4B and ATG4A results in two-stage cell cycle defects in pancreatic ductal adenocarcinoma cells.

Paalini Sathiyaseelan, Suganthi Chittaranjan, Steve E Kalloger

|Sep 30, 2022
Mapping the experiences of people with advanced cancer across multiple cancer types-a scoping review.

Steve E Kalloger, Cheryl Ho, Craig Mitton

|Oct 18, 2021
Advancing the Care of Pancreatic Cancer Patients: Moving Beyond Just Tumour Tissue.

Steve E Kalloger, Joanna M Karasinska, Cassia Warren

|Sep 21, 2020
Stroma vs epithelium-enhanced prognostics through histologic stratification in pancreatic ductal adenocarcinoma.

Steve E Kalloger, Joanna M Karasinska, Martin S Keung

|Apr 28, 2020
Genetic testing for hereditary cancer syndromes: patient recommendations for improved risk communication.

Samantha Pollard, Steve Kalloger, Deirdre Weymann

Pageof 2